IFIH1 and dermatomyositis: While IIM patients with anti-MDA5 autoantibody often exhibit cutaneous features with muscle weakness (classical dermatomyositis) or without (clinical amyopathic dermatomyositis) and develop fatal rapidly progressive ILD, especially in Asian patients [14–16].